Superficial basal cell carcinoma on face treated with 5% imiquimod cream.
No Thumbnail Available
Date
2006-09-20
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Imiquimod, an immune response modifier, is known to possess both anti-viral and anti-tumor effect. We report our experience of treating a large superficial spreading basal cell carcinoma with 5% imiquimod cream. A 65-year-old male had an asymptomatic, hyperpigmented, slowly progressive, indurated, 3 x 4 cm plaque on the left cheek for two months. Biopsy from the lesion showed features of basal cell carcinoma. The patient was treated with imiquimod 5% cream, topically three times a week for six months with complete resolution of the lesion and without any side-effects. There was no clinical or histological recurrence after three months of stopping the treatment.
Description
Keywords
Citation
Malhotra AK, Bansal A, Mridha AR, Khaitan BK, Verma KK. Superficial basal cell carcinoma on face treated with 5% imiquimod cream. Indian Journal of Dermatology, Venereology and Leprology. 2006 Sep-Oct; 72(5): 373-5